Related Experiment Video

Updated: Apr 17, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.1K

MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN

Shi-Yan Yan1, Mei-Mei Chen, Guang-Ming Li

  • 1Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Repubic of China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|February 4, 2015
PubMed

Insights

MicroRNA-32 (miR-32) is overexpressed in liver cancer, promoting tumor growth by downregulating PTEN. Inhibiting miR-32 may offer a new therapeutic strategy for hepatocellular carcinoma (HCC).

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression, implicated in cancer development.
  • MicroRNA-32 (miR-32) is recognized as an oncogene in colorectal cancer, but its role in hepatocellular carcinoma (HCC) remains unclear.

Purpose of the Study:

  • To investigate the role and mechanism of miR-32 in hepatocellular carcinoma (HCC).
  • To explore the potential of targeting miR-32 for HCC treatment.

Main Methods:

  • Quantitative real-time PCR to measure miR-32 and PTEN expression in HCC tissues and cell lines.
  • Luciferase reporter assays to confirm direct binding of miR-32 to the PTEN 3'-UTR.
  • Cell proliferation, migration, and invasion assays to assess the functional impact of miR-32 and PTEN.

Main Results:

  • miR-32 expression was significantly upregulated in HCC tissues and cell lines, inversely correlated with PTEN expression.
  • miR-32 directly targets PTEN mRNA, leading to its downregulation.
  • miR-32 promotes HCC cell proliferation, migration, and invasion through the PTEN/Akt signaling pathway.
  • Downregulation of PTEN partially reversed the inhibitory effects of miR-32 knockdown on cancer cell behaviors.

Conclusions:

  • miR-32 functions as an oncogene in HCC by suppressing PTEN expression and activating the PTEN/Akt pathway.
  • miR-32 represents a potential therapeutic target for hepatocellular carcinoma treatment.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K